Search
for
Sort by
Research 661–690 of 1000+
- Effects of finasteride on the morphology of polycystic ovaries
- Androgen replacement therapy in women
- Hormonal Treatment for Skin Androgen-Related Disorders
- Role of Nutrition in the Management of PCOS
- Wirkung von Testosteron auf Haut und Haare
- Testosterone Treatment in Women – An Overview
- Early postnatal allopregnanolone levels alteration and adult behavioral disruption in rats: Implication for drug abuse
- A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
- Behavioral and hormonal changes following the continuous administration of testosterone in females in capuchin monkey adult females (Sapajus Libidinosus)
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Estrogens and aging skin
- Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis
- Obesity and polycystic ovary syndrome
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- Management of acne
- Diagnosis of hyperandrogenism: Biochemical criteria
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Androgen receptors and their biology
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Emotion Dysregulation of Women with Premenstrual Syndrome
- Emerging treatments in alopecia
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands
- Endocrine evaluation of hirsutism
- PCOS in Adolescence and Type 2 Diabetes
- New approaches to the treatment of osteoporosis
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- New Biomarkers to Evaluate Hyperandrogenemic Women and Hypogonadal Men
- Addisonian crisis in a young man with atypical anorexia nervosa
- Is there a role for 5α‐reductase inhibitors in transgender individuals?